Announcement

Collapse

Welcome to the New Seqanswers!

Welcome to the new Seqanswers! We'd love your feedback, please post any you have to this topic: New Seqanswers Feedback.
See more
See less

ChIP-Seq: A fully Bayesian hidden Ising model for ChIP-seq data analysis.

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • ChIP-Seq: A fully Bayesian hidden Ising model for ChIP-seq data analysis.

    Syndicated from PubMed RSS Feeds

    A fully Bayesian hidden Ising model for ChIP-seq data analysis.

    Biostatistics. 2011 Sep 13;

    Authors: Mo Q

    Abstract
    Chromatin immunoprecipitation followed by next generation sequencing (ChIP-seq) is a powerful technique that is being used in a wide range of biological studies including genome-wide measurements of protein-DNA interactions, DNA methylation, and histone modifications. The vast amount of data and biases introduced by sequencing and/or genome mapping pose new challenges and call for effective methods and fast computer programs for statistical analysis. To systematically model ChIP-seq data, we build a dynamic signal profile for each chromosome and then model the profile using a fully Bayesian hidden Ising model. The proposed model naturally takes into account spatial dependency and global and local distributions of sequence tags. It can be used for one-sample and two-sample analyses. Through model diagnosis, the proposed method can detect falsely enriched regions caused by sequencing and/or mapping errors, which is usually not offered by the existing hypothesis-testing-based methods. The proposed method is illustrated using 3 transcription factor (TF) ChIP-seq data sets and 2 mixed ChIP-seq data sets and compared with 4 popular and/or well-documented methods: MACS, CisGenome, BayesPeak, and SISSRs. The results indicate that the proposed method achieves equivalent or higher sensitivity and spatial resolution in detecting TF binding sites with false discovery rate at a much lower level.


    PMID: 21914728 [PubMed - as supplied by publisher]



    More...
Working...
X